TGFBR2 and colonic neoplasm: In colon cancer, members of the miR-17–92 cluster activate Wnt/β-catenin signaling and epithelial-mesenchymal transition (35), while suppressing TGF-β signaling via direct targeting of TGFBR2, VEGFA and HIF1A (36).